SAIQA ISMAIL: Open Payments
NPI 1871794750 · DAVIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,786 in 134 payments from 20 companies in 2025. Trend: 2023 $1,594 · 2024 $2,238 · 2025 $2,786
Food & beverage: $2,783Education: $4
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $501 |
| Otsuka America Pharmaceutical, Inc. | 14 | $308 |
| Almatica Pharma LLC | 12 | $276 |
| Alkermes, Inc. | 14 | $262 |
| ABBVIE INC. | 10 | $214 |
| Janssen Pharmaceuticals, Inc | 8 | $193 |
| Axsome Therapeutics, Inc. | 9 | $188 |
| Neurocrine BioSciences, Inc. | 5 | $150 |
| Lundbeck LLC | 7 | $139 |
| Vanda Pharmaceuticals Inc. | 4 | $123 |
Products named: CAPLYTA, REXULTI, LOREEV XR, ARISTADA, Auvelity, VRAYLAR, INGREZZA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
